Detalhe da pesquisa
1.
Delphi consensus on stereotactic ablative radiotherapy for oligometastatic and oligoprogressive renal cell carcinoma-a European Society for Radiotherapy and Oncology study endorsed by the European Association of Urology.
Lancet Oncol
; 25(5): e193-e204, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38697165
2.
Salvage vesiculectomy for local prostate cancer recurrence: surgical technique and early post-operative outcomes.
World J Urol
; 42(1): 81, 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38358521
3.
Defining the optimal template of salvage lymph node dissection for unilateral pelvic nodal recurrence of prostate cancer following radical prostatectomy.
Int J Urol
; 30(1): 92-99, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36305586
4.
Elective nodal radiotherapy in prostate cancer.
Lancet Oncol
; 22(8): e348-e357, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34339655
5.
Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC): a phase II prospective trial.
BMC Cancer
; 21(1): 1113, 2021 Oct 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34663254
6.
Site-specific relapse patterns of patients with biochemical recurrence following radical prostatectomy assessed by 68Ga-PSMA-11 PET/CT or 11C-Choline PET/CT: impact of postoperative treatments.
World J Urol
; 39(2): 399-406, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32417995
7.
Neoadjuvant treatment with androgen receptor signaling inhibitors prior to radical prostatectomy: a systematic review.
World J Urol
; 39(9): 3177-3185, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33580296
8.
Development and External Validation of a Multiparametric Magnetic Resonance Imaging and International Society of Urological Pathology Based Add-On Prediction Tool to Identify Prostate Cancer Candidates for Pelvic Lymph Node Dissection.
J Urol
; 203(4): 713-718, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31718396
9.
Metastasis-directed therapy in castration-refractory prostate cancer (MEDCARE): a non-randomized phase 2 trial.
BMC Cancer
; 20(1): 457, 2020 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32448171
10.
Stereotactic robotic body radiotherapy for patients with oligorecurrent pulmonary metastases.
BMC Cancer
; 20(1): 402, 2020 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32384918
11.
Correction to: Metastasectomy for visceral and skeletal oligorecurrent prostate cancer.
World J Urol
; 38(6): 1589, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32221712
12.
Variation in adjuvant and early salvage radiotherapy after robot-assisted radical prostatectomy for prostate cancer: a population-based cohort study.
Acta Oncol
; 59(8): 904-910, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32723224
13.
Patient- versus physician-reported outcomes in prostate cancer patients receiving hypofractionated radiotherapy within a randomized controlled trial.
Strahlenther Onkol
; 195(5): 393-401, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30406289
14.
Metastasectomy for visceral and skeletal oligorecurrent prostate cancer.
World J Urol
; 37(8): 1543-1549, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-30859274
15.
Neoadjuvant degarelix with or without apalutamide followed by radical prostatectomy for intermediate and high-risk prostate cancer: ARNEO, a randomized, double blind, placebo-controlled trial.
BMC Cancer
; 18(1): 354, 2018 04 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29606109
16.
Editorial Comment.
J Urol
; 208(5): 1054-1055, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35947520
17.
Whole pelvis radiotherapy for pathological node-positive prostate cancer : Oncological outcome and prognostic factors.
Strahlenther Onkol
; 193(6): 444-451, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28101585
18.
Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer: a phase II trial.
BMC Cancer
; 17(1): 308, 2017 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28464906
19.
Post-prostatectomy radiotherapy: does late toxicity lead the game?
BJU Int
; 130(6): 705-707, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36354270
20.
Prevalence and prognosis of low-volume, oligorecurrent, hormone-sensitive prostate cancer amenable to lesion ablative therapy.
BJU Int
; 120(6): 815-821, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28646594